Literature DB >> 29679748

Remote or on-site visits were feasible for the initial setup meetings with hospitals in a multicenter surgical trial: an embedded randomized trial.

Laura Jefferson1, Caroline Fairhurst2, Stephen Brealey3, Elizabeth Coleman2, Liz Cook2, Catherine Hewitt2, Ada Keding2, Matthew Northgraves2, Amar Rangan2, Garry A Tew2, David J Torgerson2, Joseph Dias4.   

Abstract

OBJECTIVES: To investigate the effects, costs, and feasibility of providing on-site compared with remote meetings to set up hospital sites in a multicenter, surgical randomized controlled trial. STUDY DESIGN AND
SETTING: Hospitals were randomized to receive the initial trial setup meetings on-site (i.e., face-to-face) or remotely (i.e., via teleconference). Data were collected on site setup, recruitment, follow-up, and costs for the two methods. The hospital staff experience of trial setup was also surveyed.
RESULTS: Thirty-nine sites were randomized and 33 sites set up to recruit (19 on-site and 14 remote). For sites randomized to an on-site meeting compared with remote meeting respectively, the time from first contact to the first recruit was a median of 246 days (interquartile range [IQR] 196-346] vs. 212 days (IQR 154-266), mean recruitment was 10 participants (median 10, IQR 2-17) vs. 11 participants (median 6, IQR 5-23), and participant follow-up at 12 months was 81% vs. 82%. Sites allocated to an initial on-site visit cost on average £289.83 more to setup.
CONCLUSION: Remote or on-site visits are feasible for the initial setup meetings with hospitals in a multicenter surgical trial. This embedded trial should be replicated to improve generalizability and increase statistical power using meta-analysis. ISRCTN78899574.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Costs; Feasibility; Randomized controlled trial; Recruitment; Response rate; Study within a trial

Mesh:

Year:  2018        PMID: 29679748     DOI: 10.1016/j.jclinepi.2018.04.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis.

Authors:  Nicola Farrar; Daisy Elliott; Catherine Houghton; Marcus Jepson; Nicola Mills; Sangeetha Paramasivan; Lucy Plumb; Julia Wade; Bridget Young; Jenny L Donovan; Leila Rooshenas
Journal:  Trials       Date:  2022-10-20       Impact factor: 2.728

2.  Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic.

Authors:  Sharon B Love; Emma Armstrong; Carrie Bayliss; Melanie Boulter; Lisa Fox; Joanne Grumett; Patricia Rafferty; Barbara Temesi; Krista Wills; Andrea Corkhill
Journal:  Trials       Date:  2021-04-14       Impact factor: 2.279

3.  It is unprecedented: trial management during the COVID-19 pandemic and beyond.

Authors:  Eleanor J Mitchell; Khaled Ahmed; Suzanne Breeman; Seonaidh Cotton; Lynda Constable; Gillian Ferry; Kirsteen Goodman; Helen Hickey; Garry Meakin; Katy Mironov; Niamh Quann; Natalie Wakefield; Alison McDonald
Journal:  Trials       Date:  2020-09-11       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.